tiprankstipranks
Trending News
More News >

Argenx announces CHMP opinion recommending approval of Vyvgart 1000mg

Argenx (ARGX) announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended European Commission approval of Vyvgart 1000mg for subcutaneous injection as a monotherapy for the treatment of adult patients with progressive or relapsing active chronic inflammatory demyelinating polyneuropathy after prior treatment with corticosteroids or immunoglobulins.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue